News
Haverford Trust Co. elevated its position in shares of Eli Lilly and Co by 16.3%
Haverford Trust Co. lifted its position in shares of Eli Lilly and Co by 16.3% during the fourth quarter, according to the company in...
Press Releases
Novo Nordisk records for regulatory approval of long-acting factor VIII (N8-GP) in the US and the EU for treatment of haemophilia A
Novo Nordisk announced the submission of a Biologics License Applications (BLA) to the US FDA and a Marketing Authorisation Application (MAA) to the European...
Drug Research
Johnson & Johnson Human Performance Institute Invests $18 Million for future of Lake Nona Medical City
The Johnson & Johnson Human Performance Institute today announced it is expanding its footprint in the Lake Nona community in Orlando, Florida with the...
News
Cipla and Roche tie-up to sell 2 cancer drugs in India
The pharma major will distribute Tocilizumab and Syndyma -- the second brand of Roche's cancer therapy bevacizumab -- in India. This...
News
José Baselga, Named as Bristol-Myers Squibb’s M.D., Ph.D. to Board of Directors
Bristol-Myers Squibb Company announced that its Board of Directors has elected José Baselga, M.D., Ph.D., to the Board, effective March 1, 2018. Dr. Baselga...
Industry Reports
Sessa Capital Im LP decline Its Bristol Myers Squibb Co (BMY) Position by $272.76 Million
Investors sentiment increased to 1.03 in Q3 2017. Its up 0.08, from 0.95 in 2017Q2. It is positive, as 62 investors sold BMY shares...
Press Releases
Biogen, AbbVie draw Multiple Sclerosis Drug On Inflammation Reports
RBC analyst Brian Abrahams said the decision will have "zero material impact" on Biogen as Zinbryta was expected to bring in about $400 million...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read